Oxford-AstraZeneca Covid-19 vaccine news

Visit RT for stories on the Oxford-AstraZeneca Covid-19 vaccine, including breaking news and latest updates. The vaccine was developed by Oxford University, with the Cambridge-based UK-Swiss pharma company AstraZeneca to become the manufacturer – find more details on RT. In summer 2020, one of the Oxford-AstraZeneca Covid-19 vaccine variations reached phase III of the trials. In autumn 2020, several volunteers suffered side effects, like spinal inflammation, and one of them even died – read more on RT. Yet, later the vaccine was confirmed effective by UK scientists. Stay with RT to learn more on the Oxford-AstraZeneca Covid-19 vaccine creation, trials and approval, as well as on vaccination in different countries. In February 2021, the Oxford-AstraZeneca Covid-19 vaccine turned out to be only 10% effective against the new South African variation of Covid-19 – stay updated with RT. Don’t miss experts’ and analysts’ opinions on Oxford-AstraZeneca Covid-19 vaccines, as well as on the coronavirus pandemic and other diseases in general.